Health-Related Quality Of Life In Patients With Chronic Myeloid Leukemia Undergoing First Line Treatment With Imatinib For At Least Three Years Compared With The General Population: A Multicenter Study Including 448 Patients.Fabio Efficace,Michele Baccarani,Massimo Breccia,Giuliana Alimena,Gianantonio Rosti,Giorgio Lambertenghi Deliliers,Claudia Baratè,Antonella Russo Rossi,Giuseppe Fioritoni,Luigia Luciano,Diamante Turri,Francesco Nobile,Francesco Di Raimondo,Antonio Cuneo,Marco Gobbi,Pietro Leoni,Maria Pina Simula,Luciano Levato,Giuseppe Saglio,Dino Veneri,Giuseppe Leone,Alessandro Rambaldi,Simonetta Pardini,Filippo Gherlinzoni,Alfonso Zaccaria,Mario Tiribelli,Francesco Cottone,Marco Vignetti,Franco MandelliBLOOD(2010)引用 22|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要